Fuji invests in TeraRecon

TeraRecon Inc. has received a strategic capital investment from Fuji Film Co. of Tokyo, Japan.

The agreement, which occurred in March, relates to collaboration on new product and technology development. Fuji acquired 300,000 shares of newly issued series G preferred stock, representing 1.9 percent of issued equity in TeraRecon, for $4.95 million.

Under the terms of the agreement, TeraRecon will apply its signal and image processing processor and software technologies to new product and technology development with Fuji.

Fuji says it made the decision to invest after evaluation of this technology for 3D image processing and the high-speed processing of large image collections produced by modern medical imaging examinations.

TeraRecon has deployed the same technologies in its own line of end-user products including 3D and 4D image processing workstations and servers, and high-pixel density, high-resolution flat panel display systems.

Around the web

The new technology shows early potential to make a significant impact on imaging workflows and patient care. 

Richard Heller III, MD, RSNA board member and senior VP of policy at Radiology Partners, offers an overview of policies in Congress that are directly impacting imaging.
 

The two companies aim to improve patient access to high-quality MRI scans by combining their artificial intelligence capabilities.